11:14 AM EDT, 04/10/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher late Friday morning, gaining 0.75% to 1,828.19 on the S&P Europe Select ADR Index, which is up 4% for the week.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and lender Banco Bilbao Vizcaya Argentaria ( BBVA ) , which climbed 6.6% and 2% respectively. They were followed by health-tech conglomerate Royal Philips (PHG) and biopharmaceutical company Grifols ( GRFS ) , which rose 1.6% and 1.4% respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies ( DBVT ) and internet browser company Opera (OPRA), which fell 2.7% and 2.5% respectively. They were followed by internet advertising firm Criteo ( CRTO ) and pharmaceutical company Ascendis Pharma ( ASND ) , which dropped 1.8% and 1.4% respectively.

The gainers from the UK were led by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which advanced 5.1% and 4.3% respectively. They were followed by biotech company Trinity Biotech ( TRIB ) and medical device maker Smith & Nephew ( SNN ) , which were up 2.3% and 2.1% respectively.

The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics ( SLN ) and software firm Endava ( DAVA ) , which lost 4.6% and 2.1% respectively. They were followed by biopharmaceutical companies Akari Therapeutics ( AKTX ) and Amarin ( AMRN ) , which were down 1.9% and 1.5% respectively.